An integrative approach to eczema (atopic dermatitis).
This article provides an integrative treatment protocol for eczema (atopic dermatitis) using natural therapies. The protocol addresses several primary causative factors such as essential fatty acid deficiency and food allergies. In addition, it identifies a patented chamomile preparation proven in clinical studies to be as effective as hydrocortisone in relieving associated symptoms of itching and inflammation while enhancing granulation and epithelialization without deleterious side effects associated with long-term use of corticosteroid therapy.
Ross
Stephanie Maxine
SM
Certified Nutritional Consultant Faculty, Drexel University Nursing and Health Professions CE, Philadelphia, Pennsylvania, USA.
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002019:Bufexamac / Q000627:therapeutic use; D020843:Chamomile; D003876:Dermatitis, Atopic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005448:Fluocortolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005512:Food Hypersensitivity / Q000150:complications; D006636:Histamine Release; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008875:Middle Aged; D009824:Ointments / Q000627:therapeutic use; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D010946:Plants, Medicinal; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005227:Fatty Acids; D009824:Ointments; D010936:Plant Extracts; D002019:Bufexamac; D005448:Fluocortolone; C011824:fluocortin butyl ester; D006854:Hydrocortisone